![]() |
產地 | 進口、國產 |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS10012 |
應用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-Phospho-Nemo-like kinase (Thr298) |
克隆性 | |
靶點 | 詳見說明書 |
適應物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthesised phosphopeptide derived from human Nemo-like kinase around the phosphorylation site of Thr298 |
全、新、優(yōu)、品、好四大特點:
磷酸化Nemo樣激酶抗體說明書 全:公司提供上萬種產品,涵蓋了生物試劑,elisa試劑盒,標準品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細胞等,基本上各種科研所需產品在我司都能找到。
新:產品更新速度較快,基本上每周都有新產品出現。
優(yōu):產品質量好,投訴比較少。
好:我公司具有優(yōu)質的技術團隊,產品一旦售出,實驗過程中遇到困難可提供在線技術咨詢。使您使用產品時沒有任何的后顧之憂。
磷酸化Nemo樣激酶抗體說明書 英文名稱 Anti-Phospho-Nemo-like kinase (Thr298)
中文名稱 磷酸化Nemo樣激酶抗體說明書
別 名 Nemo-like kinase (Phospho-Thr298); Nemo-like kinase (Phospho-T298); p-Nemo-like kinase (Thr298); p-Nemo-like kinase (T298); DKFZp761G1211; FLJ21033; LAK1; Nemo like kinase; Nemo-like kinase; Nlk; NLK_HUMAN; Protein LAK1; Serine/threonine protein kinase NLK; Serine/threonine-protein kinase NLK.
產品屬性:
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Chicken, Pig, Cow, Rabbit, Sheep
產品類型 一抗
研究領域 細胞生物 免疫學 神經生物學 信號轉導 干細胞 細胞周期蛋白 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 58kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthesised phosphopeptide derived from human Nemo-like kinase around the phosphorylation site of Thr298
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
磷酸化Nemo樣激酶抗體說明書 產品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介紹 Nemo-like kinase (NLK) plays a role in cell fate determination and is required for differentiation of bone marrow stromal cells. It acts downstream of MAP3K7 and HIPK2 to negatively regulate the canonical Wnt/beta-catenin signaling pathway and the phosphorylation and destruction of the MYB transcription factor. It may suppress a wide range of transcription factors by phosphorylation of the coactivator, CREBBP. (referenced from swissprot)
Function : Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT*, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1.Subunit : Homodimer. Homodimerization is required for intermolecular autophosphorylation, kinase activation and nuclear localization. May interact with components of cullin-RING-based SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes. Interacts with LEF1, MEF2A, MYBL1 and MYBL2. Interacts with the upstream activating kinases HIPK2 and MAP3K7/TAK1. Interaction with MAP3K7/TAK1 seems to be indirect, and may be mediated by other proteins such as STAT3, TAB1 and TAB2. Interacts with and phosphorylates a number of transcription factors including FOXO1, FOXO3, FOXO4, MYB, NOTCH1 and TCF7L2/TCF4. Interacts with DAPK3/ZIPK, and this interaction may disrupt interaction with transcription factors such as TCF7L2/TCF4. Forms a transcriptional repressor complex with CHD7, PPARG and SETDB1. Interacts with RNF138/NARF.Subcellular Location : Nucleus. Cytoplasm. Note=Predominantly nuclear. A smaller fraction is cytoplasmic.Post-translational modifications : Phosphorylated on Thr-298. Intermolecular autophosphorylation on Thr-298 activates the enzyme.Similarity : Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.Contains 1 protein kinase domain.Database links : NCBI Reference Sequence: NP_057315.3UniProtKB/Swiss-Prot: Q9UBE8.2
實驗流程:
正在熱銷的相關產品:
CA(Human catecholamine) ELISA Kit 人兒茶酚胺Multi-class antibodies規(guī)格: 48T
Anti-LIR-8/CD85c/LILRB5 白球蛋白樣受體8抗體Multi-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh KLK10 激肽釋放酶10抗體 規(guī)格 0.1ml
TNF- Alpha ELISA KIT 大鼠壞死因子α 96T
Pan-ras 英文名稱: Pan ras抗體 0.1ml
CRHBP 英文名稱: 促腎上腺皮質激素釋放激素結合蛋白抗體 0.2ml
Anti-LIR-8/CD85c/LILRB5 白球蛋白樣受體8抗體Multi-class antibodies規(guī)格: 0.2ml
Wnt1 信號通路Wnt1抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-Phospho-Caveolin-1 (Tyr14) 磷酸化細胞質膜微囊蛋白-1抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh PCDHGC5 原鈣粘蛋白γC5抗體 規(guī)格 0.2ml
CD200 Kit Human 人 CD200 ELISA配對抗體 ELISA
TM4SF3 英文名稱: 跨膜蛋白4超家族成員3抗體 0.2ml
Phospho-cdc2* (Ser178) 英文名稱: 磷酸化細胞分裂周期蛋白25抗體 0.1ml
Anti-Phospho-Caveolin-1 (Tyr14) 磷酸化細胞質膜微囊蛋白-1抗體Multi-class antibodies規(guī)格: 0.1ml
PF/PFP(Rat Perforin/Pore-forming protein) ELISA Kit 大鼠穿孔素Multi-class antibodies規(guī)格: 48T
Anti-Bcr/CD3D/FITC 熒光素標記兔抗人、大、小鼠T淋巴細胞受體抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh ERM/Etv5 轉錄因子Ets差異基因5抗體 規(guī)格 0.2ml
Plant Vitamin E,VE EELISA Kit 植物維生素E 96T
Midnolin 英文名稱: 中腦核仁蛋白抗體 0.1ml
AER61 英文名稱: 未知糖基化轉移酶AER61抗體 0.2ml
Anti-Bcr/CD3D/FITC 熒光素標記兔抗人、大、小鼠T淋巴細胞受體抗體IgGMulti-class antibodies規(guī)格: 0.2ml
TNFSF13B Protein Cynomolgus 重組食蟹猴 BLyS / TNFSF13B / BAFF 蛋白 (Fc 標簽)
CoC1(懸浮)
ERBB2 Others Mouse 小鼠 HER2 / ErbB2 人細胞裂解液 (陽性對照)
MRC-5-EGFP+puro人胚 MRC-5-EGFP+puro in human embryo lung fibroblasts MEM+10%Hyclone滅活血清+2ug/ml puromycin
人*導管癌細胞;CFPAC-1
人角膜上皮細胞 (HcorF)( 5×105 ) 293T, SV40轉化的人胚腎上皮細胞系 Human
CL-0451SW-13(人腎上腺皮質癌細胞)5×106cells/瓶×2
CTSS Others Mouse 小鼠 Cathepsin S / CTSS 人細胞裂解液 (陽性對照)
大鼠角膜上皮細胞完全培養(yǎng)基 100mL
Hep3B人細胞 Hep3B human hepatocarcinoma cells DMEM+10% FBS
IL18 Protein Human 重組人 IL18 / Ierleukin 18 / IGIF 蛋白 (GST 標簽)
NCI-H520(人肺鱗癌細胞) 5×106cells/瓶×2 A549 [A-549](細胞)
磷酸化Nemo樣激酶抗體說明書 TNFSF13B Protein Cynomolgus 重組食蟹猴 BLyS / TNFSF13B / BAFF 蛋白 (Fc 標簽)
CoC1(懸浮)
ERBB2 Others Mouse 小鼠 HER2 / ErbB2 人細胞裂解液 (陽性對照)
MRC-5-EGFP+puro人胚 MRC-5-EGFP+puro in human embryo lung fibroblasts MEM+10%Hyclone滅活血清+2ug/ml puromycin
人*導管癌細胞;CFPAC-1
人角膜上皮細胞 (HcorF)( 5×105 ) 293T, SV40轉化的人胚腎上皮細胞系 Human
技術外包服務:
★磷酸化Nemo樣激酶抗體說明書 分子生物學:質粒抽提、PCR、Q-PCR、RT-PCR、分子生物學:基因合成、引物合成、基因測序、載體構建等
★蛋白工程:原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程:細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構建、細胞RNAi技術等等。